174 related articles for article (PubMed ID: 29487749)
1. Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers.
Srinivasan M; Meadows ML; Maxwell L
Biochem Res Int; 2018; 2018():7463796. PubMed ID: 29487749
[TBL] [Abstract][Full Text] [Related]
2. Measurement of salivary resistin, visfatin and adiponectin levels.
Mamali I; Roupas ND; Armeni AK; Theodoropoulou A; Markou KB; Georgopoulos NA
Peptides; 2012 Jan; 33(1):120-4. PubMed ID: 22108712
[TBL] [Abstract][Full Text] [Related]
3. Serum and salivary adipokines in type 2 diabetes - Results of a pilot study in India.
Vinitha R; Yogalakshmi R; Rajeswari A; Snehalatha C; Nair DR; Susairaj P; Satheesh K; Nanditha A; Raghavan A; Arun KV; Ramachandran A
Diabetes Metab Syndr; 2022 Jul; 16(7):102536. PubMed ID: 35717896
[TBL] [Abstract][Full Text] [Related]
4. Salivary resistin level and its association with insulin resistance in obese individuals.
Abdalla MMI
World J Diabetes; 2021 Sep; 12(9):1507-1517. PubMed ID: 34630903
[TBL] [Abstract][Full Text] [Related]
5. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
6. Relation of Osteoprotegerin, Visfatin and Ghrelin to Metabolic Syndrome in Type 2 Diabetic Patients.
Ahmed MB; Ismail MI; Meki AR
Int J Health Sci (Qassim); 2015 Apr; 9(2):127-39. PubMed ID: 26309431
[TBL] [Abstract][Full Text] [Related]
7. Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.
Zanardini R; Benussi L; Fostinelli S; Saraceno C; Ciani M; Borroni B; Padovani A; Binetti G; Ghidoni R
J Alzheimers Dis; 2018; 61(3):1053-1060. PubMed ID: 29226876
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes Mellitus Coincident with Clinical and Subclinical Thyroid Dysfunctions Results in Dysregulation of Circulating Chemerin, Resistin and Visfatin.
Tabandeh MR; Taha AS; Addai Ali H; Razijalali M; Mohammadtaghvaei N
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830883
[TBL] [Abstract][Full Text] [Related]
9. Literature-based discovery of salivary biomarkers for type 2 diabetes mellitus.
Srinivasan M; Blackburn C; Mohamed M; Sivagami AV; Blum J
Biomark Insights; 2015; 10():39-45. PubMed ID: 26005324
[TBL] [Abstract][Full Text] [Related]
10. Measurement of salivary resistin level in patients with type 2 diabetes.
Yin J; Gao H; Yang J; Xu L; Li M
Int J Endocrinol; 2012; 2012():359724. PubMed ID: 22969799
[TBL] [Abstract][Full Text] [Related]
11. Does metabolic control affect salivary adipokines in type 2 diabetes mellitus?
Teke E; Kırzıoğlu FY; Korkmaz H; Calapoğlu M; Orhan H
Dent Med Probl; 2019; 56(1):11-20. PubMed ID: 30951617
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".
Caso F; Postiglione L; Covelli B; Ricciardone M; Di Spigna G; Formisano P; D'Esposito V; Girolimetto N; Tasso M; Peluso R; Navarini L; Ciccozzi M; Margiotta DPE; Oliviero F; Afeltra A; Punzi L; Del Puente A; Scarpa R; Costa L
Clin Rheumatol; 2019 Sep; 38(9):2547-2552. PubMed ID: 31147798
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.
Chen MP; Chung FM; Chang DM; Tsai JC; Huang HF; Shin SJ; Lee YJ
J Clin Endocrinol Metab; 2006 Jan; 91(1):295-9. PubMed ID: 16234302
[TBL] [Abstract][Full Text] [Related]
14. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
[TBL] [Abstract][Full Text] [Related]
15. Role of adipocytokines and its correlation with endocrine pancreatic function in patients with pancreatic cancer.
Gąsiorowska A; Talar-Wojnarowska R; Kaczka A; Borkowska A; Czupryniak L; Małecka-Panas E
Pancreatology; 2013; 13(4):409-14. PubMed ID: 23890140
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
[TBL] [Abstract][Full Text] [Related]
18. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
